| 中晚期肝癌介入治疗及预后分析 |
| |
| 引用本文： | 吴光兴,陈恩碧,谢美强.中晚期肝癌介入治疗及预后分析[J].现代临床医学生物工程学杂志,2005,11(2):110-112. |
| |
| 作者姓名： | 吴光兴 陈恩碧 谢美强 |
| |
| 作者单位： | 广东医学院附属湛江中心人民医院肿瘤科 湛江524037
(吴光兴，陈恩碧)，广东医学院附属湛江中心人民医院肿瘤科 湛江524037(谢美强) |
| |
| 摘 要： | 目的探讨中晚期肝癌的治疗方法和预后因素.方法将我院323例住院的中晚期肝癌患者,经股动脉穿刺行肝动脉灌注化疗栓塞术(Transcatheterarterialchemoembolization,TACE)的病例资料进行回顾性分析,依据影像学,血生化指标及生存时间判断疗效.结果323例患者术后肿块缩小占60.3%,症状改善,1年生存率48.9%,2年生存率6.2%,3年生存率4.9%,中位生存期14.9个月.结论介入治疗是中晚期肝癌的有效治疗手段,可减轻症状,延长患者寿命,但要注意并发症的发生.
|
| 关 键 词： | 中晚期肝癌 介入治疗 疗效 预后 |
| 文章编号： | 1008-634X(2005)02-0110-03 |
| 修稿时间： | 2005年2月8日 |
Interventioned Therapy and Prognostic Anlysis of Advanced Hepatocellular Carcinoma |
| |
| WU Guang-xing,CHEN En-bi,XIE Mei-qiang.Interventioned Therapy and Prognostic Anlysis of Advanced Hepatocellular Carcinoma[J].Journal of Modern Clinical Medical Bioengineering,2005,11(2):110-112. |
| |
| Authors: | WU Guang-xing CHEN En-bi XIE Mei-qiang |
| |
| Abstract: | ObjectiveTo study the therapeutic means and prognostic anlysis of advanced hepatocellular carcinoma. Methods323 patients with advanced hepatocellular carcinama ,who received transcatheter arterial chemoembolization (TACE),clinical data got through follow-up were analyzed retrospectively on. Imagiology ,biochemical index and the survival time were observed. ResultsThe overall effective rate of the TACE patients was 60.3%, the survival rates of 1,2 and 3 years were 48.9%,6.2% and 4.9%,mediam survival times was 14.9 months. ConclusionsInterventioned therapy is a effective therapeutic means for advanced hepatocellular carcinoma ,and improve quality of life and survival time. But we must pay attention to complications rates. |
| |
| Keywords: | Hepatocellular neoplasms Interventioned therapy Curative effect Prognosis |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
